医学
最后
皮肤病科
沙利度胺
银屑病
斑块性银屑病
头皮
钉子(扣件)
药品
银屑病性关节炎
指甲病
内科学
药理学
冶金
材料科学
多发性骨髓瘤
作者
Jorge Magdaleno‐Tapial,Cristian Valenzuela‐Oñate,José María Ortiz Salvador,Daniela Subiabre-Ferrer,P. Hernández‐Bel
摘要
Nail psoriasis can cause great morbidity and a negative impact on the personal and work-related life of the patients. However, it responds more poorly to most drug therapies. Classically, the first line of treatment for nail psoriasis has been topical medication, but the new biological drugs seem to be the most effective treatment. Apremilast is another systemic oral drug that has shown a significant reduction of the severity in moderate-severe plaque psoriasis, as well as nail and scalp psoriasis. We present two cases of patients who exhibited a rapid response to treatment with apremilast.
科研通智能强力驱动
Strongly Powered by AbleSci AI